查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417199

霍乱疫苗市场报告：2030 年趋势、预测与竞争分析

Cholera Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

霍乱疫苗趋势与预测

预计2030年，全球霍乱疫苗市场将达到1,553.8亿美元，2024年至2030年复合年增长率为9.0%。该市场的主要驱动力是人们对霍乱预防的认识和承诺不断增强、政府主导的努力以及为实现集体行动和通用目标而加强的全球合作。全球霍乱疫苗市场的未来看起来充满希望，医院和诊所、研究机构和学术实验室市场充满机会。

霍乱疫苗市场洞察

Lucintel 预测，与霍乱弧菌 O1 相比，含有重组 b次单元的全细胞将在预测期内经历最高的生长。

医院和诊所将继续成为市场的最大部分。

预计北美地区在预测期内将出现最高的成长。

常问问题

Q.1 霍乱疫苗的市场规模有多大？

A1. 预计2030年，全球霍乱疫苗市场规模将达到1,553.8亿美元。

Q.2 霍乱疫苗市场的成长预测为何：

A2. 2024年至2030年，全球霍乱疫苗市场预计将以9.0%的复合年增长率成长。

Q.3 影响霍乱疫苗市场成长的关键因素有哪些：

A3. 该市场的主要驱动力是人们对霍乱预防的认识和承诺不断增强，政府主导的倡议和全球合作推动集体行动和朝着通用目标取得进展。

Q4.市场的主要细分市场是：

A4. 霍乱疫苗市场的未来看起来充满希望，医院和诊所、研究和学术实验室市场都有机会。

Q5.市场的主要企业是：

A5. 主要的霍乱疫苗公司如下。

  • Astellas Pharma
  • Celldex Therapeutics
  • Emergent BioSolutions
  • Eubiologics
  • Johnson &Johnson
  • Merck
  • Pfizer
  • PharmaChoice Canada
  • Sanofi
  • Takeda Pharmaceutical Company Limited

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，与霍乱弧菌 O1 相比，含有重组 b次单元的全细胞在预测期内将具有最高的生长速度。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 预计北美在预测期内将经历最高的成长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球霍乱疫苗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球霍乱疫苗市场趋势（2018-2023）与预测（2024-2030）
  • 按疫苗类型分類的全球霍乱疫苗市场
    • 霍乱弧菌 O1 与含有重组 b次单元的全细胞
    • 杀死口服 O1 和 O139
  • 全球霍乱疫苗市场（按产品）
    • 杜科拉尔
    • 山哲
    • 瓦克乔拉
    • Ubicol 和 Ubicol Plus
    • 其他的
  • 按最终用途行业分類的全球霍乱疫苗市场
    • 医院和诊所
    • 研究与学术机构
    • 其他的

第四章 2018-2030年区域市场趋势及预测分析

  • 全球霍乱疫苗市场区域分布
  • 北美霍乱疫苗市场
  • 欧洲霍乱疫苗市场
  • 亚太霍乱疫苗市场
  • 其他地区霍乱疫苗市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按疫苗类型分類的全球霍乱疫苗市场成长机会
    • 全球霍乱疫苗市场成长机会（按产品）
    • 按最终用途产业分類的全球霍乱疫苗市场成长机会
    • 全球霍乱疫苗市场成长机会（按地区）
  • 全球霍乱疫苗市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球霍乱疫苗市场产能
    • 全球霍乱疫苗市场的併购、收购与合资企业
    • 认证和许可

第七章主要企业概况

  • Astellas Pharma
  • Celldex Therapeutics
  • Emergent BioSolutions
  • Eubiologics
  • Johnson & Johnson
  • Merck
  • Pfizer
  • PharmaChoice Canada
  • Sanofi
  • Takeda Pharmaceutical Company Limited
简介目录

Cholera Vaccine Trends and Forecast

The future of the global cholera vaccine market looks promising with opportunities in the hospitals and clinics and research and academic laboratories markets. The global cholera vaccine market is expected to reach an estimated $155.38 billion by 2030 with a CAGR of 9.0% from 2024 to 2030. The major drivers for this market are growing awareness and efforts towards cholera prevention and government-driven initiatives and global collaborations are fostering collective action and progress towards common goals.

A more than 150-page report is developed to help in your business decisions.

Cholera Vaccine by Segment

The study includes a forecast for the global cholera vaccine by vaccine type, product, end use industry, and region.

Cholera Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Whole Cell V. Cholerae O1 with Recombinant B-Subunit
  • Killed Oral O1 and O139

Cholera Vaccine Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Dukoral
  • Shanchol
  • Vaxchora
  • Euvichol and Euvichol-Plus

Cholera Vaccine Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Clinics
  • Research and Academic Laboratories
  • Others

Cholera Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cholera Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cholera vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cholera vaccine companies profiled in this report include-

  • Astellas Pharma
  • Celldex Therapeutics
  • Emergent Biosolutions
  • Eubiologics
  • Johnson & Johnson
  • Merck
  • Pfizer
  • Pharmachoice Canada
  • Sanofi
  • Takeda Pharmaceutical Company Limited

Cholera Vaccine Market Insights

Lucintel forecasts that whole cell v. cholerae O1 with recombinant b-subunit is expected to witness highest growth over the forecast period.

Within this market, hospitals and clinics will remain the largest segment.

North America is expected to witness highest growth over the forecast period.

Features of the Global Cholera Vaccine Market

Market Size Estimates: Cholera vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cholera vaccine market size by vaccine type, product, end use industry, and region in terms of value ($B).

Regional Analysis: Cholera vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine type, product, end use industry, and regions for the cholera vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cholera vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cholera vaccine market size?

Answer: The global cholera vaccine market is expected to reach an estimated $155.38 billion by 2030.

Q.2 What is the growth forecast for cholera vaccine market?

Answer: The global cholera vaccine market is expected to grow with a CAGR of 9.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cholera vaccine market?

Answer: The major drivers for this market are growing awareness and efforts towards cholera prevention and government-driven initiatives and global collaborations are fostering collective action and progress towards common goals.

Q4. What are the major segments for cholera vaccine market?

Answer: The future of the cholera vaccine market looks promising with opportunities in the hospitals and clinics and research and academic laboratories markets.

Q5. Who are the key cholera vaccine market companies?

Answer: Some of the key cholera vaccine companies are as follows.

  • Astellas Pharma
  • Celldex Therapeutics
  • Emergent BioSolutions
  • Eubiologics
  • Johnson & Johnson
  • Merck
  • Pfizer
  • PharmaChoice Canada
  • Sanofi
  • Takeda Pharmaceutical Company Limited

Q6. Which cholera vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that whole cell v. cholerae O1 with recombinant b-subunit is expected to witness highest growth over the forecast period.

Q7. In cholera vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cholera vaccine market by vaccine type (whole cell V. cholerae O1 with recombinant B-subunit and killed oral O1 and O139), product (dukoral, shanchol, vaxchora, euvichol and euvichol-plus, and others), end use industry (hospitals and clinics, research and academic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cholera Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cholera Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cholera Vaccine Market by Vaccine Type
    • 3.3.1: Whole Cell V. Cholerae O1 with Recombinant B-Subunit
    • 3.3.2: Killed Oral O1 and O139
  • 3.4: Global Cholera Vaccine Market by Product
    • 3.4.1: Dukoral
    • 3.4.2: Shanchol
    • 3.4.3: Vaxchora
    • 3.4.4: Euvichol and Euvichol-Plus
    • 3.4.5: Others
  • 3.5: Global Cholera Vaccine Market by End Use Industry
    • 3.5.1: Hospitals and Clinics
    • 3.5.2: Research and Academic Laboratories
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cholera Vaccine Market by Region
  • 4.2: North American Cholera Vaccine Market
    • 4.2.2: North American Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
  • 4.3: European Cholera Vaccine Market
    • 4.3.1: European Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
    • 4.3.2: European Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
  • 4.4: APAC Cholera Vaccine Market
    • 4.4.1: APAC Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
    • 4.4.2: APAC Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others
  • 4.5: ROW Cholera Vaccine Market
    • 4.5.1: ROW Cholera Vaccine Market by Vaccine Type: Whole Cell V. Cholerae O1 with Recombinant B-Subunit and Killed Oral O1 and O139
    • 4.5.2: ROW Cholera Vaccine Market by End Use Industry: Hospitals and Clinics, Research and Academic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cholera Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Cholera Vaccine Market by Product
    • 6.1.3: Growth Opportunities for the Global Cholera Vaccine Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Cholera Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Cholera Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cholera Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cholera Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Astellas Pharma
  • 7.2: Celldex Therapeutics
  • 7.3: Emergent BioSolutions
  • 7.4: Eubiologics
  • 7.5: Johnson & Johnson
  • 7.6: Merck
  • 7.7: Pfizer
  • 7.8: PharmaChoice Canada
  • 7.9: Sanofi
  • 7.10: Takeda Pharmaceutical Company Limited